Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Lidia Giraudo Diego"'
Autor:
Giovanni Grignani, Dario Sangiolo, Carmine Dell'Aglio, Massimo Aglietta, Cristina Cammarata, Fabrizio Carnevale-Schianca, Susanna Gallo, Loretta Gammaitoni, Franca Fagioli, Lidia Giraudo Diego, Wanda Piacibello, Alessandro Cignetti, Noela Jordaney, Giulia Mesiano, Maja Todorovic, Valeria Leuci, Ymera Pignochino, Angela Rita Elia
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997). 35(7)
Cytokine-induced killer cells (CIKs) are ex vivo expanded T-NK lymphocytes capable of HLA-unrestricted antitumor activity. CIKs are promising candidates for adoptive cancer immunotherapies; they can be generated and infused in autologous settings of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df0f74f9bac9c1055afd3101ff2bacd1
https://pubmed.ncbi.nlm.nih.gov/22892454
https://pubmed.ncbi.nlm.nih.gov/22892454
Autor:
Lidia Giraudo Diego, Valeria Leuci, Dario Sangiolo, Loretta Gammaitoni, Massimo Aglietta, Franca Fagioli, Maja Todorovic, Wanda Piacibello, Giulia Mesiano, Fabrizio Carnevale-Schianca
Publikováno v:
Expert opinion on biological therapy. 12(6)
Cytokine-induced killer (CIK) cells are heterogeneous ex vivo-expanded T lymphocytes with mixed T-NK phenotype and endowed with a wide MHC-unrestricted antitumor activity. CIK cells can be expanded from peripheral blood mononuclear cells (PBMC) cultu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68a014e9b5293bfba9f3d6621e9f4f7b
https://pubmed.ncbi.nlm.nih.gov/22500927
https://pubmed.ncbi.nlm.nih.gov/22500927
Autor:
Lorenzato, Annalisa, Martino, Cosimo, Dani, Nadia, Oligschläger, Yvonne, Ferrero, Anna Maria, Biglia, Nicoletta, Calogero, Raffaele, Olivero, Martina, Di Renzo, Maria Flavia
Publikováno v:
FASEB Journal; Jun2012, Vol. 26 Issue 6, p2446-2456, 11p